Director Tina Nova Receives 23,931 Stock Options at Aurinia Pharmaceuticals

Tina Susan Nova, a director of Aurinia Pharmaceuticals Inc., received a grant of 23,931 stock options on June 4, 2026. The options have an exercise price of $15.67 per share and will vest one year from the grant date, with an expiration date of June 4, 2036. This transaction represents an award of derivative securities (Director Stock Options) to acquire common shares of the company. Following this transaction, Ms. Nova holds 23,931 options in total. The filing was signed on June 8, 2026, and reports the director's ownership change as required by Section 16 of the Securities Exchange Act. This is a standard equity compensation grant to a board member.